Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT03539393
Eligibility Criteria:
Inclusion Criteria:
* Eligible patients may enter this CUP after successfully completing TV48125-CNS-30084 and all End of Study procedures
* In the opinion of your physician/investigator are able to continue IMP (fremanezumab) in a safe and compliant way.
Exclusion Criteria:
* Additional criteria may apply, please contact your physician/investigator for more information.
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
17 Years
Study:
NCT03539393
Study Brief:
Protocol Section:
NCT03539393